Universal Ibogaine Inc.
IBOGF · OTC
7/31/2022 | 7/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5 | $4 | $0 | $0 |
| SG&A Expenses | $5 | $4 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $4 | $0 | $0 |
| Operating Income | $0 | -$4 | $0 | -$0 |
| % Margin | 46.4% | – | – | – |
| Other Income/Exp. Net | -$6 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$10 | -$4 | -$0 | -$0 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$10 | -$4 | -$0 | -$0 |
| % Margin | -980.2% | – | – | – |
| EPS | -0.057 | -0.031 | -0.01 | -0.01 |
| % Growth | -82.8% | -209% | 0% | – |
| EPS Diluted | -0.057 | -0.031 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 186 | 125 | 12 | 10 |
| Weighted Avg Shares Out Dil | 186 | 125 | 12 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$4 | $0 | -$0 |
| % Margin | -430.3% | – | – | – |